Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN   US75886F1075

Delayed Quote. Delayed Nasdaq - 04/22 04:00:01 pm
311.68 USD   +3.21%
2d ago Studies find new drugs greatly lower cholesterol
7d ago NASDAQ 100 MOVERS : Lltc, yhoo
04/14 REGENERON PHARMACEUTICALS : Yale University Assigned Patent
 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/15/2014 04/16/2014 04/17/2014 04/21/2014 04/22/2014 Date
288.08(c) 300.14(c) 296.74(c) 302(c) 311.68(c) Last
1 100 448 972 925 607 221 454 407 736 072 Volume
-0.67% +4.19% -1.13% +1.77% +3.21% Change
More quotes
Company
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company. It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions. Regeneron markets medicines for eye diseases, colorectal cancer and a rare inflammatory condition and... 
Sector
Biotechnology
Calendar
05/08Earnings Release
Surperformance© rating of Regeneron Pharmaceuticals
Trading Rating : Investor Rating :
More about the company
Chart REGENERON PHARMACEUTICALS
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 2 685 M
EBIT 2014 984 M
Net income 2014 598 M
Finance 2014 1 534 M
Yield 2014 -
Sales 2015 3 369 M
EBIT 2015 1 467 M
Net income 2015 847 M
Finance 2015 2 867 M
Yield 2015 -
PER 2014 64,72
PER 2015 42,65
EV / Sales 2014 10,7x
EV / Sales 2015 8,11x
Capitalization 30 178 M
More Financials
Latest news on REGENERON PHARMACEUTICALS
2d ago Studies find new drugs greatly lower cholesterol
7d ago NASDAQ 100 MOVERS : Lltc, yhoo
04/14 REGENERON PHARMACEUTICALS : Yale University Assigned Patent
04/11 REGENERON PHARMACEUTICALS : to Report First Quarter 2014 Financial and Operating..
04/10 REGENERON PHARMACEUTICALS : Announces Initiative for STEM Education in Hudson Va..
04/10 REGENERON PHARMACEUTICALS : Sanofi : and Regeneron Report Positive Results With ..
04/09 REGENERON PHARMACEUTICALS : Change in Directors or Principal Officers (form 8-K)
04/09 NASDAQ 100 MOVERS : Isrg, regn
04/08 REGENERON PHARMACEUTICALS : Introduces Initiative for STEM Education in Hudson V..
04/08 REGENERON PHARMACEUTICALS : Launches Initiative for STEM Education in Hudson Val..
04/04 Momentum names may see more pain
04/04 REGENERON PHARMACEUTICALS : Robert A. Ingram Elected to Regeneron Board of Direc..
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
Regeneron Pharmaceuticals  : Income Statement Evolution
More Financials
EPS Revisions
Regeneron Pharmaceuticals  : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF